Depakine: 25 years in Russia

Karlov V.A.

doi:https://doi.org/10.17116/jnevro2017117111129-134

Karlov V.A.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Depakine: 25 years in Russia

Authors:

Karlov V.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11): 129‑134

DOI: 10.17116/jnevro2017117111129-134

Read: 18276 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Karlov VA. Depakine: 25 years in Russia. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11):129‑134. (In Russ.)
https://doi.org/10.17116/jnevro2017117111129-134

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):14-19

Absence status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56

Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136

Autonomic cardiovascular disorders in patients with epileptic and psychogenic non-epileptic seizures: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):13-20

Febrile infection-related epilepsy syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):34-40

The potential of cortical electrical stimulation for the study of autonomic dysfunction in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):25-34

The role of neuroinflammation in the development of seizure activity and autonomic disorders in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):50-58

Epileptogenesis and risk factors of symptomatic epileptic seizures in patients with acute cerebrovascular accidents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):26-31

Therapies for focal epilepsy associated with brain tumors. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):14-20

A personalized approach to the diagnosis of epilepsy in obese children. Laboratory Service. 2025;(1):5-12

Abstract:

The article summarizes domestic and international studies on the development and clinical investigation of valproates including multiple studies of a research team directed by the author. Valproate targets are considered in biological and clinical aspects. A spectrum of action and advantages of the brand drug (depakine) compared to generics and other antiepileptic drugs are discussed. A number of recommendations for practitioners about using valproates are proposed.

Keywords:

epilepsy

valproic acid

valproates

depakine

generics

antiepileptic drugs

Authors:

Karlov V.A.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Close metadata

References:

Avoli M, Rogawski MA, Avanzini G. Generalized epileptic disordes: an update. Epilepsia. 2001;42(4):445-457. https://doi.org/10.1046/j.1528-1157.2001.39800.x
Bouwman BM, Suffsynsky P, Midzynovsky IS, et al. The effects of vigabatrin on spike and wave discharges in WAG/Rij rats. Epilepsy Res. 2007;76(1):34-40. https://doi.org/10.1016/j.eplepsyres.2007.06.006
Karlov VA. Epilepsiya. M.: Medicina; 1990. (In Russ.)
PRAC Recommends the restrictions on the use of valproate un women and girls. EMA/612389/2014.
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London: Royal College of Physicians (UK). Issued: January 2012 last modified: December 2013. NICE clinical guideline 137.
Zhidkova I, Karlov V, Adamyan L. Ehpilepsiya i reproduktivnoe zdorov’e zhenshchiny. Klinicheskie, patogeneticheskie i terapevticheskie aspekty. Palmarium academic publishing. 2012;278. (In Russ.)
Vlasov PN. Use of valproates in women of childbearing age and pregnant women with epilepsy. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:4-9. (In Russ.) https://doi.org/10.14412/2074-2711-2015-IS-4-9
Vlasov PN. Algorithms of using valproic acid drugs in women. Zh Nevrol Psikhiatr Im. S.S. Korsakova. 2015;4:36-40. (In Russ.) https://doi.org/10.17116/jnevro20151154136-40
The opinion of the Expert Council on the use of valproates in epileptic patients. Neurology, Neuropsychiatry, Psychosomatics. 2015;1(Special):63-64. (In Russ.) https://doi.org/10.14412/2074-2711-2015-1S-63-64
Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lanced. 2016;15(2):210-218. https://doi.org/10.1016/S1474-4422(15)00314-2
Zenkov LR. Neparoksizmal’nye ehpilepticheskie rasstrojstva. M.: Medpressinform; 2007. (In Russ.)
Mohanraj R, Brodie MJ. Pharmacological outcome in early diagnosed epilepsy. Epilepsy Behavior. 2005;6(3):382-387. https://doi.org/10.1016/j.yebeh.2005.01.008
Kwan P, Brodie MJ. Epilepsy after the first drug fails: substitution or add-on? Seizure. 2000;9:464-468. https://doi.org/10.1053/seiz.2000.0442
Karlov VA, Vlasov PN, Andreeva OV. Novye vozmozhnosti primeneniya depakina pri ehpilepsii. Psihiatriya i psihofarmatika. 2003;3:11-12. (In Russ.)
Vlasov PN, Karlov VA, Andreeva OV. Depakin v nevrologii. Materialy IXRossijskogo nacional’nogo kongressa «Chelovek i lekarstvo». M.: Far-Medinfo; 2002. (In Russ.)
Marson AG, Asya MD, Muna A, Apelyonn R, Baker GA, et al. Th SANAD study of effectiveness of valproate, lamotrigine, or topirpmate for generalized and unclassification epilepsy: an unblended randomized controlled trial. Lanced. 2007;1016-1026.
Trinka E, Marson AG, Paesschen WV, et al. KOMET: an unblended, randomized, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. Neuropsychiatry. 2011.
Milul A, Iudice A, Adami M, et al. Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: An Italian multicenter prospective observational study. Epilepsy and Behavior. 2013;28(3):494-500. https://doi.org/10.1016/j.yebeh.2013.05.038
Rudakova IG. Kombinnirovannaya antiehpilepticheskaya terapiya. Ehpilepsiya. 2015;3(18):5-9. (In Russ.)
Marson AG, Al-Khanusi AM, MBBCh, Awaid M, MBBCH, Appleton R, MA(Oxon) et al.
Belousov YuB, Leonova MV, SHtejnberg LL, Tishchenkova IF, Sokolov AV. Primenenie antikonvul’santov s pozicij monitoringa koncentracii: sovremennye dannye. Farmateka. 2014;7:98-101. (In Russ.)
Sokolov AV, Belousov YuB, Tishchenkova IE. Sravnitel’naya farmakokinetika preparatov val’proevoj kisloty s kontroliruemym vysvobozhdeniem. Remedium (Specvypusk.) 2006;4:2-7. (In Russ.)
Vlasov PN, Orekhova NV, SHagrova EV. EHffektivnost’ i perenosimost’ val’proatov pri ih vynuzhdennoj zamene. Farmateka. 2008;5:1-3. (In Russ.)
Belousov YuB, Bystrickaya LN, Afanas’eva EA. Kliniko-ehkonomicheskij analiz mikrogranulirovannoj formy val’proevoj kisloty pri fokal’noj ehpilespii vzroslyh (real’naya praktika naznachenij). Kachestvennaya klinicheskaya praktika. 2016;1:4-13. (In Russ.)
Zenkov LR. Val’proevaya kislota v retro- i perspektive. Nevrologicheskij zhurnal. 2005;6:37-42. (In Russ.)
Karlov VA. Ehpilepsiya u detej i vzroslyh, zhenshchin i muchin. M.: Medicina; 2010. (In Russ.)
Vlasov PN. Fokal’nye ehpilepsii: vybor protivoehpilepticheskih preparatov v poliklinicheskih usloviyah. Nevrologiya, nejropsihiatriya, psihosomatika (Specvypusk №1 Ehpilepsiya). 2016;4-10. (In Russ.)